SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-003862
Filing Date
2017-03-09
Accepted
2017-03-09 16:31:46
Documents
82
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K snss-10k_20161231.htm 10-K 3628217
2 EX-23.1 snss-ex231_772.htm EX-23.1 20859
3 EX-31.1 snss-ex311_722.htm EX-31.1 16567
4 EX-31.2 snss-ex312_723.htm EX-31.2 16782
5 EX-32.1 snss-ex321_724.htm EX-32.1 9891
6 GRAPHIC g2017030917114768730311.jpg GRAPHIC 26253
7 GRAPHIC g2017030917113976830310.jpg GRAPHIC 55946
  Complete submission text file 0001564590-17-003862.txt   10972563

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT snss-20161231.xml EX-101.INS 2284076
9 XBRL TAXONOMY EXTENSION SCHEMA snss-20161231.xsd EX-101.SCH 73162
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20161231_cal.xml EX-101.CAL 57882
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20161231_def.xml EX-101.DEF 211909
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20161231_lab.xml EX-101.LAB 529457
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20161231_pre.xml EX-101.PRE 398309
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 17678911
SIC: 2834 Pharmaceutical Preparations